WuXi PharmaTech (Cayman) Inc. (02359) invests approximately 30 million euros to acquire a 3.22% stake in a French biopharmaceutical fund.

Zh tng cijng APP xn, yo mng kng d (02359) gng b, 2025 nin 12 yu 18 r, gngs qunz zgngs WuXi Lux Holding y Jeito Capital S.A.S. (yxi jinchng "gunl gngs" hu "Jeito Capital")qinsh Subscription Agreement, yudng yu WuXi Lux Holding rnqu tuz jjn 1,000 wn uyun de A li fn', duy y jj tuz jjn fn' de 1.07%. Tng r, WuXi Lux Holding y WuXi PharmaTech Healthcare Fund I L.P. (yxi jinchng "WuXi Fund I") qinsh Transfer Agreement (xichng "zhunrng xiy"), yudng WuXi Lux Holding nzho zujn yq tuz rnku jngzchn zhzhi h wi chz rnqu jingz wuXi Fund i chyu de 2,000 wn uyun jjn rnqu fn'.